When JW van Zyl Inc is engaged · 03
Appointing or changing a South African distributor or regulatory holder.
A regulated product line already has a South African footprint, and something structural is changing: a distributor is being terminated or replaced, the regulatory holder is transferring, a product is being acquired, or the supply arrangement is moving. Product responsibility, warranty exposure, the indemnity chain and the regulatory position all move at once, and the transition window is where the mistakes surface.
Who this is for
Pharmaceutical, medical-device and diagnostics companies with products already on the South African market, and the distributors and holders who serve them
Typically instructed by: Regional and country legal counsel · supply chain and commercial · regulatory affairs · quality
What tends to go wrong
Where this workstream fails without South African counsel
- Termination triggers a stockholding, warranty and post-market surveillance dispute that the original agreement never scoped.
- The regulatory-holder transfer stalls at SAHPRA and the product is out of market for months.
- The outgoing distributor holds documentation the incoming one cannot obtain.
- Post-market obligations survive the change in ways nobody drafted for.
Scope
What JW van Zyl Inc owns in this workstream
- Termination and transition
- Termination documentation, transition terms and the sequencing that keeps product on the market while responsibility moves.
- Regulatory-holder transfer
- The transfer plan for the registration or licence, and the SAHPRA interface strategy, coordinated with regulatory affairs.
- Successor agreements
- Successor distribution, agency, wholesale and supply agreements, including territory, exclusivity, forecasting and exit.
- Warranty, PMS and PV allocation
- How warranty, post-market surveillance and pharmacovigilance obligations are allocated across the transition and after it.
- Documentation and records
- Transfer and retention of the technical, regulatory and commercial records the incoming party needs to operate.
- Change of control and transferability
- Review of change-of-control clauses and licence transferability across the contracts affected by the change.
Outside this workstream
What the firm does not take on here
- Commercial negotiation with the outgoing distributor beyond the legal architecture of the exit.
- Product-specific regulatory-affairs submissions.
How the workstream is instructed
Discovery, scoping, engagement
- Discovery. You set out the product line, the parties on each side of the change and the date by which responsibility must have moved.
- Scoping. The firm runs a conflicts check and, where several contracts are affected, an Initial Matter Assessment at a fixed fee that maps the transition and its risk points.
- Engagement. Scope, deliverables, fees and timelines are agreed in writing before the transition documents are drafted.
Timing and fee shapeA distributor or holder transition is engaged as a fixed fee for the scoped documents, with a bounded hourly estimate where the outgoing party's position is not yet known. Continuing support after the transition runs on a monthly retainer.
Illustrative situations from prior professional experience are available on request. Anonymised matters comparable to this work are listed under Experience.
Before you instruct
What helps the firm assess the matter
- The parties on each side of the change and any related entities, for the conflicts check.
- The products affected and who currently holds their registrations or licences.
- The existing distribution or supply agreement and any notice already given.
- The date by which the change must be complete.
Free tool
Before you instruct, work through the checklist
Use the South Africa market-entry checklist · the route-to-market and regulatory-holder questions a transition reopens.